Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Lohmann

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 11, 2016
Influence of blood-brain barrier permeability on O-(2-<sup>18</sup>F-fluoroethyl)-L-tyrosine uptake in rat gliomasCarina Stegmayr, Ulrike Bandelow, Dennis Oliveira, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2019
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRIJan-Michael Werner, Gabriele Stoffels, Thorsten Lichtenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2017
Spatial Relationship of Glioma Volume Derived from <sup>18</sup>F-FET PET and Volumetric MR Spectroscopy Imaging: A Hybrid PET/MRI StudyJörg Mauler, Andrew A Maudsley, Karl-Josef Langen, et al.
Nuklearmedizin. Nuclear Medicine|May 20, 2025
Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024Thomas Wendler, Julian Manuel Michael Rogasch, Moritz B Bastian, et al.
Nuklearmedizin. Nuclear Medicine|April 17, 2025
Digitalization of Nuclear Medicine in Germany - Status Quo 2024Thomas Wendler, Julian Manuel Michael Rogasch, Moritz B Bastian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2018
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastomaPhilipp Lohmann, Pantelis Stavrinou, Katharina Lipke, et al.
Neuro-Oncology Advances|May 20, 2021
Combined <sup>18</sup>F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changesFrancesco D'Amore, Farida Grinberg, Jörg Mauler, et al.
World Neurosurgery|August 6, 2018
Correlation of Dynamic O-(2-[<sup>18</sup>F]Fluoroethyl)-L-Tyrosine Positron Emission Tomography, Conventional Magnetic Resonance Imaging, and Whole-Brain Histopathology in a Pretreated Glioblastoma: A Postmortem StudyPhilipp Lohmann, Marc D Piroth, Bernd Sellhaus, et al.
Zeitschrift Fur Medizinische Physik|May 11, 2026
Applications of artificial intelligence in nuclear medicineLena Kaiser, Thomas Wendler, Deni Hardiansyah, et al.
Neuro-Oncology Advances|September 26, 2025
Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastomaIsabelle Stetter, Jan-Michael Werner, Michael Wollring, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Nuclear Medicine and Molecular Imaging|September 11, 2016
Influence of blood-brain barrier permeability on O-(2-<sup>18</sup>F-fluoroethyl)-L-tyrosine uptake in rat gliomasCarina Stegmayr, Ulrike Bandelow, Dennis Oliveira, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2019
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRIJan-Michael Werner, Gabriele Stoffels, Thorsten Lichtenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2017
Spatial Relationship of Glioma Volume Derived from <sup>18</sup>F-FET PET and Volumetric MR Spectroscopy Imaging: A Hybrid PET/MRI StudyJörg Mauler, Andrew A Maudsley, Karl-Josef Langen, et al.
Nuklearmedizin. Nuclear Medicine|May 20, 2025
Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024Thomas Wendler, Julian Manuel Michael Rogasch, Moritz B Bastian, et al.
Nuklearmedizin. Nuclear Medicine|April 17, 2025
Digitalization of Nuclear Medicine in Germany - Status Quo 2024Thomas Wendler, Julian Manuel Michael Rogasch, Moritz B Bastian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2018
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastomaPhilipp Lohmann, Pantelis Stavrinou, Katharina Lipke, et al.
Neuro-Oncology Advances|May 20, 2021
Combined <sup>18</sup>F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changesFrancesco D'Amore, Farida Grinberg, Jörg Mauler, et al.
World Neurosurgery|August 6, 2018
Correlation of Dynamic O-(2-[<sup>18</sup>F]Fluoroethyl)-L-Tyrosine Positron Emission Tomography, Conventional Magnetic Resonance Imaging, and Whole-Brain Histopathology in a Pretreated Glioblastoma: A Postmortem StudyPhilipp Lohmann, Marc D Piroth, Bernd Sellhaus, et al.
Zeitschrift Fur Medizinische Physik|May 11, 2026
Applications of artificial intelligence in nuclear medicineLena Kaiser, Thomas Wendler, Deni Hardiansyah, et al.
Neuro-Oncology Advances|September 26, 2025
Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastomaIsabelle Stetter, Jan-Michael Werner, Michael Wollring, et al.
Pageof 14